MaxCyte, Inc. Common Stock (MXCT) Stock Price

MXCTStock

$1.22−12.23%52W

Market Cap$125.91M

P/E—

PEG Ratio—

Div yield—

Beta1.46

MXCT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)42.50%

Price vs S&P 500 (4W)12.48%

VGM Score38.56

Book Value / Share (Quarterly)$1.57

P/TBV (Annual)0.97x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-9.30%

Cash Flow / Share (Quarterly)$-0.28

Price vs S&P 500 (YTD)-34.11%

Gross Margin (TTM)80.51%

Net Profit Margin (TTM)-121.16%

EPS (TTM)$-0.37

10-Day Avg Trading Volume0.53M

EPS Excl Extra (TTM)$-0.37

Revenue Growth (5Y)4.76%

EPS (Annual)$-0.42

ROI (Annual)-26.02%

Gross Margin (Annual)81.16%

Net Profit Margin (5Y Avg)-88.57%

Cash / Share (Quarterly)$1.00

Revenue Growth QoQ (YoY)-7.11%

ROA (Last FY)-22.04%

Revenue Growth TTM (YoY)-14.30%

EBITD / Share (TTM)$-0.39

ROE (5Y Avg)-15.76%

Operating Margin (TTM)-141.81%

Cash Flow / Share (Annual)$-0.34

P/B Ratio0.95x

P/B Ratio (Quarterly)0.45x

Net Income / Employee (Annual)$-490,400

EV / Revenue (TTM)4.51x

Net Interest Coverage (TTM)-20.44x

ROA (TTM)-18.85%

EPS Incl Extra (Annual)$-0.42

Current Ratio (Annual)8.30x

Quick Ratio (Quarterly)10.88x

3-Month Avg Trading Volume1.09M

52-Week Price Return-12.23%

Revenue / Employee (TTM)$354,800

Tangible BV / Share (Quarterly)$1.56

P/S Ratio (Annual)4.85x

Asset Turnover (Annual)0.16x

52-Week High$1.86

Operating Margin (5Y Avg)-104.43%

EPS Excl Extra (Annual)$-0.42

CapEx CAGR (5Y)-3.10%

Tangible BV CAGR (5Y)66.92%

26-Week Price Return54.43%

Quick Ratio (Annual)7.47x

13-Week Price Return4.27%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)12.04x

Enterprise Value$145.59M

Revenue / Share Growth (5Y)-3.81%

Asset Turnover (TTM)0.16x

Book Value / Share Growth (5Y)45.14%

Revenue / Employee (Annual)$362,900

Inventory Turnover (Annual)0.76x

Pretax Margin (Annual)-135.14%

Cash / Share (Annual)$0.96

3-Month Return Std Dev63.78%

Gross Margin (5Y Avg)85.81%

Net Income / Employee (TTM)$-429,900

ROE (Last FY)-26.02%

EPS Basic Excl Extra (Annual)$-0.42

Receivables Turnover (TTM)6.61x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.37

Receivables Turnover (Annual)8.07x

ROI (TTM)-22.03%

P/S Ratio (TTM)4.96x

Pretax Margin (5Y Avg)-88.57%

Revenue / Share (Annual)$0.31

Tangible BV / Share (Annual)$1.60

Price vs S&P 500 (52W)-30.79%

Year-to-Date Return-21.29%

5-Day Price Return-12.23%

EPS Normalized (Annual)$-0.42

ROA (5Y Avg)-13.65%

Net Profit Margin (Annual)-135.14%

Month-to-Date Return16.19%

Cash Flow / Share (TTM)$-0.33

EBITD / Share (Annual)$-0.45

Operating Margin (Annual)-157.14%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-15.76%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.37

P/TBV (Quarterly)0.45x

P/B Ratio (Annual)0.96x

Inventory Turnover (TTM)0.79x

Pretax Margin (TTM)-121.16%

Book Value / Share (Annual)$1.61

Price vs S&P 500 (13W)2.32%

Beta1.46x

Revenue / Share (TTM)$0.30

ROE (TTM)-22.03%

52-Week Low$0.64

vGradeC

gGradeD

mGradeC

vgmGradeD

MXCT Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 12, 2026	-$0.09	-$0.08	+14.28%(+$0.01)
Q4 2025	Mar 24, 2026	-$0.08	-$0.06	+32.08%(+$0.03)
Q3 2025	Nov 12, 2025	-$0.10	-$0.09	+12.22%(+$0.01)
Q2 2025	Aug 6, 2025	-$0.10	-$0.12	-17.65%(-$0.02)

MXCT Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.15

4.25

Industry Peers — R&D — Physical Sciences(16)

Symbol	Value Score	Growth Score	Momentum Score	Price
MXCTMaxCyte, Inc. Common Stock	C	D	C	$1.22
IQVIQVIA Holdings Inc.	D	C	A	$261.75
INCYIncyte Genomics Inc	C	A	B	$124.37
MEDPMedpace Holdings, Inc. Common Stock	F	B	B	$600.65
CRLCharles River Laboratories International, Inc.	D	D	B	$291.50
ICLRIcon Plc	C	C	B	$170.02
ABSIAbsci Corporation Common Stock	F	F	A	$8.71
OABIOmniAb, Inc. Common Stock	D	C	A	$4.47
NRCNRC Health Common Stock	D	D	B	$21.85
IBACIB Acquisition Corp. Common Stock	—	D	C	$10.89
ONMDOneMedNet Corp Class A Common Stock	D	C	D	$0.58
ISPCiSpecimen Inc. Common Stock	D	F	F	$1.54
BIAFbioAffinity Technologies, Inc. Common Stock	A	F	F	$4.87
BIAFWbioAffinity Technologies, Inc. Warrant	—	—	F	$0.08
NOTVInotiv, Inc. Common Stock	A	B	F	$0.01
OABIWOmniAb, Inc. Warrant	—	—	A	$0.25
ONMDWOneMedNet Corp Warrant	—	—	D	$0.03

About MaxCyte, Inc. Common Stock

MaxCyte Inc is a commercial cell engineering company that develops and commercializes technologies for the discovery and development of next-generation cell therapeutics. The company's proprietary Flow Electroporation platform enables the efficient engineering of diverse cell types for therapeutic and research applications. MaxCyte generates revenue from the sale and licensing of its instruments and related single-use disposable processing assemblies.